Actively Recruiting
Analysis of Various Treatment Methods of Granulomatous Lobular Mastitis
Led by First Affiliated Hospital of Harbin Medical University · Updated on 2024-08-22
350
Participants Needed
1
Research Sites
8 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Granulomatous lobular mastitis (GLM) is a rare benign breast disease that is difficult to distinguish from breast cancer based on clinical and imaging findings, and there is currently no standard treatment. This study aims to analyze the clinical characteristics and demographic data of GLM patients and to compare the overall effectiveness of three treatment methods: surgery alone, triple anti-tuberculosis drug therapy alone, and combined surgery with triple anti-tuberculosis drug therapy, with the goal of providing new insights for clinical treatment.
CONDITIONS
Official Title
Analysis of Various Treatment Methods of Granulomatous Lobular Mastitis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Female patients aged 15 to 65 years who are not breastfeeding
- Histopathological confirmation of granulomatous lobular mastitis
- Normal liver and kidney function
You will not qualify if you...
- Pregnant or breastfeeding women
- Allergies to rifampin, isoniazid, or ethambutol
- Presence of malignant breast tumors
- Severe underlying diseases
- Other conditions judged unsuitable by the investigator
- Refusal to participate in the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
First affiliated hospital of Harbin medical university
Harbin, Heilongjiang, China, 150001
Actively Recruiting
Research Team
Y
Yi Zhou
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here